OmegaGenesis has formed a senior management team that provides the
leadership experience required to build and grow a leading
biotechnology company. Our executive team brings decades of
leadership experience in scientific research, product development
and the growth of technology companies.
| Name | Position |
|---|---|
| Oostur Raza | Co-Founder, CEO and President |
| Salah Sedarous, Phd | Co-Founder, Chief Technology Officer |
| Dennis Kushner | Chief Financial Officer |
| Don Morrison | Executive Vice President |
| Gene Jamieson | Director, Product Development |
Oostur Raza, Co-Founder, President and CEO of OmegaGenesis has over
40 years of engineering, technology, business and executive
experience. Oostur's management roles include: General Electric,
Fujitsu , Adobe, Sun Microsystems, and a variety of other
technology companies. Oostur started his career as a Nuclear
Engineer with General Electric where he designed nuclear plant fuel
and cores and worked with rare earth elements. He is the recipient
GE Thomas Edison Award and has a MS in Nuclear Engineering from the
University of Wisconsin.
Salah Sedarous Ph.D. is Chief Technology Officer and Co-founder of OmegaGenesis. Salah leads OmegaGenesis research and development efforts and coordinates the Company's work with the Mayo Clinic research team. Previous experience includes: Chief Scientist for Pemstar, Inc., Research Scientist & Fellow, Biochemistry and Molecular Biology at the Mayo Clinic for 13 years. Salah received his Ph.D. in Physics, North Dakota State University, and MBA in Management, University of Saint Thomas.
Dennis Kushner, Chief Financial Officer, is responsible for the Company's finances, administration and operations. Dennis brings over 30 years of management experience in finance, accounting, and operations. Previous experience includes: Managing Director, Catapult Consulting Associates, providing corporate finance, management and accounting services, raising capital, mergers and acquisitions, and interim CFO and COO assignments; and Deloitte and Touche providing consulting services to life sciences, biotechnology, and health care companies such as; Genentech, Affymetrix, Applied Biosystems, Kaiser, Gilead Sciences and Varian. Dennis received his MPA from the University of Southern California and a Bachelor of Science in finance and accounting from the University of Southern California.
Don Morrison, Executive Vice President, is responsible for the Company's partnerships, industry relations, marketing and strategic planning. Don brings 28 years of operating and executive experience building companies from early stage to public companies. Previous experience includes: President of Chordiant; CEO of Remend; Vice President Marketing, Nielsen/SMI; Vice President, Sales, SCO: and VP Marketing, Altos/Acer Computers. Don serves on a number of early stage venture funded boards. Don received his MBA, Golden Gate University and BS Business, San Francisco State University.
Gene Jamieson is Director, Product Development and leads OmegaGenesis' product development, product test programs, pre-clinical and clinical trial preparations and oversees the San Jose laboratory. Previous experience includes: Director, Product Development and FDA, Jazz Pharmaceuticals Inc.; Vice President, Pharmaceutical Sciences, NeurogesX Inc.; Director, Quality Assurance and Control (FDA), Centaur. Director, Laboratory Operations, Balazs Analytical Laboratories and Director, Quality Control and Pharmaceutical Sciences (FDA), Nycomed Salutar. Gene holds 12 patents and has participated in 35 scientific publications. Gene received his BS in Chemistry, Northern Illinois University.
Salah Sedarous Ph.D. is Chief Technology Officer and Co-founder of OmegaGenesis. Salah leads OmegaGenesis research and development efforts and coordinates the Company's work with the Mayo Clinic research team. Previous experience includes: Chief Scientist for Pemstar, Inc., Research Scientist & Fellow, Biochemistry and Molecular Biology at the Mayo Clinic for 13 years. Salah received his Ph.D. in Physics, North Dakota State University, and MBA in Management, University of Saint Thomas.
Dennis Kushner, Chief Financial Officer, is responsible for the Company's finances, administration and operations. Dennis brings over 30 years of management experience in finance, accounting, and operations. Previous experience includes: Managing Director, Catapult Consulting Associates, providing corporate finance, management and accounting services, raising capital, mergers and acquisitions, and interim CFO and COO assignments; and Deloitte and Touche providing consulting services to life sciences, biotechnology, and health care companies such as; Genentech, Affymetrix, Applied Biosystems, Kaiser, Gilead Sciences and Varian. Dennis received his MPA from the University of Southern California and a Bachelor of Science in finance and accounting from the University of Southern California.
Don Morrison, Executive Vice President, is responsible for the Company's partnerships, industry relations, marketing and strategic planning. Don brings 28 years of operating and executive experience building companies from early stage to public companies. Previous experience includes: President of Chordiant; CEO of Remend; Vice President Marketing, Nielsen/SMI; Vice President, Sales, SCO: and VP Marketing, Altos/Acer Computers. Don serves on a number of early stage venture funded boards. Don received his MBA, Golden Gate University and BS Business, San Francisco State University.
Gene Jamieson is Director, Product Development and leads OmegaGenesis' product development, product test programs, pre-clinical and clinical trial preparations and oversees the San Jose laboratory. Previous experience includes: Director, Product Development and FDA, Jazz Pharmaceuticals Inc.; Vice President, Pharmaceutical Sciences, NeurogesX Inc.; Director, Quality Assurance and Control (FDA), Centaur. Director, Laboratory Operations, Balazs Analytical Laboratories and Director, Quality Control and Pharmaceutical Sciences (FDA), Nycomed Salutar. Gene holds 12 patents and has participated in 35 scientific publications. Gene received his BS in Chemistry, Northern Illinois University.